Board advisory

Pre-IPO board build. Post-acquisition governance restructure. Independent director for an EU MDR transition you cannot afford to get wrong. We have placed that board member before, in MedTech, in your exact situation.

The Problems We Solve

Your MDR transition needs a board member who has already governed one.

We place directors with direct regulatory and clinical experience matched to your specific compliance pathway.

The Problems We Solve

Expanding into new markets requires board members who have operated across regulatory systems, not just studied them.

Our board director search matches governance expertise with geographic fluency.

The Problems We Solve

Investors evaluate the board before they evaluate the technology.

We place independent directors and chairs who signal governance maturity and accelerate funding rounds.

The Problems We Solve

Board succession planning in MedTech is not a calendar exercise. It is triggered by submissions, acquisitions, and funding milestones.

We plan transitions around the events that drive your business.

The Problems We Solve

Your MDR transition needs a board member who has already governed one.

We place directors with direct regulatory and clinical experience matched to your specific compliance pathway.

The Problems We Solve

Investors evaluate the board before they evaluate the technology.

We place independent directors and chairs who signal governance maturity and accelerate funding rounds.

The Problems We Solve

Expanding into new markets requires board members who have operated across regulatory systems, not just studied them.

Our board director search matches governance expertise with geographic fluency.

The Problems We Solve

Board succession planning in MedTech is not a calendar exercise. It is triggered by submissions, acquisitions, and funding milestones.

We plan transitions around the events that drive your business.

Measurable Impact

The numbers behind the work.

logo_shape
20+Board Members
Appointed over the past 5 years
logo_shape
50%+Of Them
Were with VC-backed MedTech companies
logo_shape
50+Profiles Engaged on Average
The depth of outreach behind every shortlist
logo_shape
2000+Active Board Member Profiles
Chairs, NEDs, and advisory board members currently embedded in the global MedTech ecosystem